-
Ageility Physical Therapy Solutions Partners with National Senior Games Association
Post on 5/7/19
-
Bicycle Therapeutics Enters Neuroscience Arena through Collaboration with Dementia Discovery Fund
Post on 5/7/19
-
Verve Therapeutics Raises $58.5M in Series A Funding Led by GV
Post on 5/7/19
-
AMAG Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update
Post on 5/7/19
-
Bioasis Announces Private Placement
Post on 5/6/19
-
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post on 5/6/19
-
Magenta Therapeutics Closes Public Offering of Common Stock
Post on 5/6/19
-
Covetrus Announces New Partnership with Mars Petcare
Post on 5/6/19
-
Epizyme Provides Business Update and Reports First Quarter 2019 Financial Results
Post on 5/6/19
-
Immunogen Inc (IMGN) Q1 2019 Earnings Call Transcript
Post on 5/6/19
-
Dicerna Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post on 5/5/19
-
Cadence Acquires Arcor Laser Services
Post on 5/3/19
-
Ironwood Pharmaceuticals Inc (IRWD) Q1 2019 Earnings Call Transcript
Post on 5/3/19
-
Anika Announces $50 Million Share Repurchase Program
Post on 5/2/19
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 5/2/19
-
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 5/2/19
-
Translate Bio Announces $47.5 Million Private Placement
Post on 5/2/19
-
Agios Reports Business Highlights and First Quarter 2019 Financial Results
Post on 5/2/19
-
Evelo Biosciences Reports First Quarter 2019 Financial Results and Recent Business Highlights
Post on 5/2/19
-
Momenta Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results
Post on 5/2/19
-
Biogen's Share Price Will Likely Be Under Pressure If Zolgensma Receives FDA Approval
Post on 5/2/19
-
Magenta Therapeutics Prices Public Offering
Post on 5/1/19
-
XRHealth Announces Partnership with Healing HealthCare Systems
Post on 4/30/19
-
AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)
Post on 4/30/19
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 4/30/19